Details of Host Protein
Host Protein General Information (ID: PT1065) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Protein Name |
Small ubiquitin-related modifier 1 (SUMO1)
|
Gene Name |
SUMO1
|
||||||
Host Species |
Homo sapiens
|
Uniprot Entry Name |
SUMO1_HUMAN
|
||||||
Protein Families |
Ubiquitin family
|
||||||||
Subcellular Location |
Nucleus membrane; PML body Cell membrane Nucleus
|
||||||||
External Link | |||||||||
NCBI Gene ID | |||||||||
Uniprot ID | |||||||||
Ensembl ID | |||||||||
HGNC ID | |||||||||
Function in Host |
Ubiquitin-like protein that can be covalently attached toproteins as a monomer or a lysine-linked polymer. Covalent attachmentvia an isopeptide bond to its substrates requires prior activation bythe E1 complex SAE1-SAE2 and linkage to the E2 enzyme UBE2I, and can bepromoted by E3 ligases such as PIAS1-4, RANBP2 or CBX4. This post-translational modification on lysine residues of proteins plays acrucial role in a number of cellular processes such as nucleartransport, DNA replication and repair, mitosis and signal transduction. Involved for instance in targeting RANGAP1 to the nuclear pore complexprotein RANBP2. Covalently attached to the voltage-gated potassiumchannel KCNB1; this modulates the gating characteristics of KCNB1. Polymeric SUMO1 chains are also susceptible topolyubiquitination which functions as a signal for proteasomaldegradation of modified proteins. May also regulate a network of genesinvolved in palate development. Covalently attached to ZFHX3.
[1-7]
Click to Show/Hide
|
||||||||
Related KEGG Pathway | |||||||||
Nucleocytoplasmic transport | hsa03013 | Pathway Map | |||||||
Fluid shear stress and atherosclerosis | hsa05418 | Pathway Map | |||||||
3D Structure |
|
Full List of Virus RNA Interacting with This Protien | |||||||||
---|---|---|---|---|---|---|---|---|---|
RNA Region: Not Specified Virus Region (hCoV-19/England/02/2020 ) | |||||||||
RNA Region Details | RNA Info Click to show the detail information of this RNA binding region | [8] | |||||||
Strains Name |
hCoV-19/England/02/2020
|
||||||||
Strains Family |
Beta (B.1.351)
|
||||||||
RNA Binding Region |
Not Specified Virus Region
|
||||||||
Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
Infection Cells | Calu-3 cells (Human lung cancer cell) (CVCL_0609 ) | ||||||||
Cell Originated Tissue | Lung | ||||||||
Infection Time | 24 h | ||||||||
Interaction Score | P-adjust = 0.007 | ||||||||
Method Description | UV protein-RNA crosslinking; RNA interactome capture (cRIC); RNA antisense purification coupled with mass spectrometry (RAP-MS) |
Differential Gene Expression During SARS-COV-2 Infection | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Protein Phosphorylation after Virus Infection | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T76
[9] |
Protein Sequence Information |
MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV
Click to Show/Hide
|
---|